Texts and rewards to help teens stick with HIV treatment
Part of Infections clinical trials.
This trial tests whether text messages and small rewards help adolescents stay on their HIV medication. It is for teens aged 15-19 who have been on treatment for at least a year.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 19 years old
- You have been taking HIV medication (ART) for at least one year
- You plan to continue your treatment at the study clinic
- You are willing to receive text messages and could earn small rewards
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether daily text message reminders and a small tracking device (WisePill) can help people who recently started HIV medication stay on track. It's designed for people who began treatment in the past 2 months and are willing to receive texts and use the device.
This study tests a program that uses text messages and a personal health coach to help Latino men with HIV take their medication every day. It's designed for those who have had trouble sticking to their HIV medicine routine.
This study tests a program called Motivation Matters! to help people with HIV who have traded sex for things they need get started on HIV medication and stay healthy. It uses text messages to support you.
This trial tests a program to help people with HIV stay on track with their medication. If you take HIV medication, sometimes miss doses, and use stimulants, this program may offer support to improve your health.
This study tests whether a mobile health app or text-based tool can help young people with HIV stay on top of their treatment and medical appointments. The goal is to make it easier to manage HIV care using your phone.
This trial tests a text-messaging program to help young guys who have sex with guys stay HIV-negative. It's designed for teens and young adults who own a cell phone and can take a quick HIV test at home.
Hear when a new Antiretroviral Therapy (ART) Adherence Among Adolescents Living With HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.